Browse > Article
http://dx.doi.org/10.14348/molcells.2019.2395

Combination Therapy with a PI3K/mTOR Dual Inhibitor and Chloroquine Enhances Synergistic Apoptotic Cell Death in Epstein-Barr Virus-Infected Gastric Cancer Cells  

Kim, Mi-Young (Digestive Disease Center, CHA Bundang Medical Center, CHA University)
Kruger, Annie J. (Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School)
Jeong, Ju-Yeon (Institute for Clinical Research, CHA Bundang Medical Center, CHA University)
Kim, Jaehee (Institute for Clinical Research, CHA Bundang Medical Center, CHA University)
Shin, Phil kyung (Institute for Clinical Research, CHA Bundang Medical Center, CHA University)
Kim, Sun Young (Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Cho, Joo Young (Digestive Disease Center, CHA Bundang Medical Center, CHA University)
Hahm, Ki Baik (Digestive Disease Center, CHA Bundang Medical Center, CHA University)
Hong, Sung Pyo (Digestive Disease Center, CHA Bundang Medical Center, CHA University)
Publication Information
Molecules and Cells / v.42, no.6, 2019 , pp. 448-459 More about this Journal
Abstract
The phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway is a promising target for gastric cancer (GC) treatment; however the efficacy of PI3K/mTOR dual inhibitors in GC has not yet been maximized. Additionally, the effect of autophagy regulation by PI3K/mTOR dual inhibitors has not been clearly elucidated in GC treatment. We aimed to show that our newly developed PI3K/mTOR dual inhibitor, CMG002, when combined with an autophagy inhibitor, chloroquine (CQ), potently induces effective cancer cell death in Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC) cells, where both the PI3K/AKT/mTOR and autophagy pathways play important roles in disease pathogenesis. EBV- and mock-infected AGS and NUGC3 GC cell lines were treated with CMG002 +/- CQ. PI3K/AKT/mTOR signaling pathway mediators, cellular apoptosis and autophagy markers were confirmed by Western blot assay. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay. CMG002 effectively blocked the PI3K/AKT/mTOR pathway by markedly decreasing phosphorylation of AKT and its downstream mediator S6. CMG002 induced G0/G1 cell cycle arrest and enhanced apoptotic cell death in AGS and NUGC3 cells, particularly EBV-infected cells compared with mock-infected cells, as confirmed by flow cytometric analyses and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assays. The combination of CMG002 plus CQ synergistically increased apoptotic cell death in EBV-infected GC cell lines when compared with CMG002 alone (P < 0.05). Our results suggest that the new PI3K/mTOR dual inhibitor, CMG002, when used in combination with the autophagy inhibitor, CQ, provides enhanced therapeutic efficacy against EBVaGC.
Keywords
apoptosis; autophagy; chloroquine; gastric cancer; PI3K/mTOR dual inhibitor;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ghadimi, M.P., Lopez, G., Torres, K.E., Belousov, R., Young, E.D., Liu, J., Brewer, K.J., Hoffman, A., Lusby, K., Lazar, A.J., et al. (2012). Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors. Mol. Cancer Ther. 11, 1758-1769.   DOI
2 Hart, S., Novotny-Diermayr, V., Goh, K.C., Williams, M., Tan, Y.C., Ong, L.C., Cheong, A., Ng, B.K., Amalini, C., Madan, B., et al. (2013). VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. Mol. Cancer Ther. 12, 151-161.   DOI
3 Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009). Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 69, 2766-2774.   DOI
4 Imai, S., Nishikawa, J., and Takada, K. (1998). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72, 4371-4378.   DOI
5 Ji, Y., Di, W., Yang, Q., Lu, Z., Cai, W., and Wu, J. (2015). Inhibition of autophagy increases proliferation inhibition and apoptosis induced by the PI3K/mTOR inhibitor NVP-BEZ235 in breast cancer cells. Clin. Lab. 61, 1043-1051.
6 Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C.M., Adams, P.D., Adeli, K., et al. (2016). Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1-222.   DOI
7 Levine, B., and Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell 132, 27-42.   DOI
8 Liu, P., Begley, M., Michowski, W., Inuzuka, H., Ginzberg, M., Gao, D., Tsou, P., Gan, W., Papa, A., Kim, B.M., et al. (2014). Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 508, 541-545.   DOI
9 Ning, C., Liang, M., Liu, S., Wang, G., Edwards, H., Xia, Y., Polin, L., Dyson, G., Taub, J.W., Mohammad, R.M., et al. (2017). Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. Oncotarget 8, 44295-44311.   DOI
10 Mirzoeva, O.K., Hann, B., Hom, Y.K., Debnath, J., Aftab, D., Shokat, K., and Korn, W.M. (2011). Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma. J. Mol. Med. (Berl.) 89, 877-889.   DOI
11 Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S.M., Riggins, G.J., et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554.   DOI
12 Shair, K.H., Schnegg, C.I., and Raab-Traub, N. (2008). EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 68, 6997-7005.   DOI
13 Zhang, C.Η., Awasthi, N., Schwarz, M.A., and Schwarz, R.E. (2013). The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer. Int. J. Oncol. 43, 1627-1635.   DOI
14 Akiyama, S., Amo, H., Watanabe, T., Matsuyama, M., Sakamoto, J., Imaizumi, M., Ichihashi, H., Kondo, T., and Takagi, H. (1988). Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NUGC-4. Jpn. J. Surg. 18, 438-446.   DOI
15 Shibata, D., and Weiss, L.M. (1992). Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 140, 769-774.
16 Shimizu, S. (2018). Biological roles of alternative autophagy. Mol. Cells 41, 50-54.   DOI
17 Shin, J.Y., Kim, J.O., Lee, S.K., Chae, H.S., and Kang, J.H. (2010). LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer 10, 425.   DOI
18 Soares, H.P., Ming, M., Mellon, M., Young, S.H., Han, L., Sinnet-Smith, J., and Rozengurt, E. (2015). Dual PI3K/mTOR inhibitors induce rapid overactivation of the MEK/ERK pathway in human pancreatic cancer cells through suppression of mTORC2. Mol. Cancer Ther. 14, 1014-1023.   DOI
19 Chang, Z., Shi, G., Jin, J., Guo, H., Guo, X., Luo, F., Song, Y., and Jia, X. (2013). Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Int. J. Mol. Med. 31, 1449-1456.   DOI
20 Bhattacharya, B., Akram, M., Balasubramanian, I., Tam, K.K., Koh, K.X., Yee, M.Q., and Soong, R. (2012). Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells. Cancer Biol. Ther. 13, 34-42.   DOI
21 Eisenberg-Lerner, A., Bialik, S., Simon, H.U., and Kimchi, A. (2009). Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 16, 966-975.   DOI
22 Chen, Y.R., Liu, M.T., Chang, Y.T., Wu, C.C., Hu, C.Y., and Chen, J.Y. (2008). Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. J. Virol. 82, 8124-8137.   DOI
23 Choi, P.R., Kang, Y.J., Sung, B., Kim, J.H., Moon, H.R., Chung, H.Y., Kim, S.E., Park, M.I., Park, S.J., and Kim, N.D. (2015). MHY218-induced apoptotic cell death is enhanced by the inhibition of autophagy in AGS human gastric cancer cells. Int. J. Oncol. 47, 563-572.   DOI
24 Dawson, C.W., Tramountanis, G., Eliopoulos, A.G., and Young, L.S. (2003). Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278, 3694-3704.   DOI
25 Fang, W.L., Huang, K.H., Lan, Y.T., Lin, C.H., Chang, S.C., Chen, M.H., Chao, Y., Lin, W.C., Lo, S.S., Li, A.F., et al. (2016). Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers. Oncotarget 7, 6201-6220.   DOI
26 Fukagawa, Y., Nishikawa, J., Kuramitsu, Y., Iwakiri, D., Takada, K., Imai, S., Satake, M., Okamoto, T., Fujimoto, M., Okita, K., et al. (2008). Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway. Electrophoresis 29, 3192-3200.   DOI
27 Zhu, Y., Tian, T., Zou, J., Wang, Q., Li, Z., Li, Y., Liu, X., Dong, B., Li, N., Gao, J., et al. (2015). Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer. BMC Cancer 15, 894.   DOI
28 Fei, H.R., Tian, H., Zhou, X.L., Yang, M.F., Sun, B.L., Yang, X.Y., Jiao, P., and Wang, F.Z. (2016). Inhibition of autophagy enhances effects of PF-04691502 on apoptosis and DNA damage of lung cancer cells. Int. J. Biochem. Cell Biol. 78, 52-62.   DOI